Biomarkers in Bone Marrow Supernatant for Predicting AML Chemosensitivity
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to AML
Related studies linked through entity extraction aliases.
Azacitidine + Venetoclax VS Azacitidineas Maintenance Therapy in AML
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Phase1b/2 Trial Of AZA + APG1252 In Patients With High-Risk AML
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases
- Status
- RECRUITING
- Phase
- PHASE2
Venetoclax, Azacitidine and Liposomal Mitoxantrone for Newly Diagnosed AML
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Phase 1 Study of CG009301 for Injection in Adult Subjects With Recurrent or Refractory Haematological Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Safety and Efficacy of CLL1 CAR-T Followed by Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Leptin: A Marker for AML Chemo-Sensitivity
- Status
- RECRUITING
- Phase
- N/A
QH101 Cell Therapy Relapsed/Refractory(R/R) Acute Myeloid Leukemia(AML) and Myelodysplastic Syndromes(MDS)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
The Efficacy and Safety Assessment of Allogeneic γδ T Cells in Patients With MRD-positive AML After Allo-HSCT
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Incidence and Risk Factors for the Development of Invasive Fungal Infection in Patients Diagnosed With Acute Myeloblastic Leukemia (HIFA)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
The Mutation Profile and Prognosis in AML With IDH1/2 Mutation
- Status
- TERMINATED
- Phase
- N/A
A Long Term Follow-up Study of TScan TCR-T Products
- Status
- RECRUITING
- Phase
- N/A
A Randomized Study to Compare Post-transplant Cyclophosphamide, Sirolimus, Ruxolitinib and Post-transplant Cyclophosphamide, Sirolimus, Mycophenolate Mofetil to Prevent Graft Versus Host Disease
- Status
- RECRUITING
- Phase
- PHASE2
Molecular Genetics Guide the Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Conditioning Regimen in Elderly AML Patients Receiving Haplo-HSCT.
- Status
- NOT_YET_RECRUITING
- Phase
- NA
CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)
- Status
- RECRUITING
- Phase
- PHASE1
Mitoxantrone Hydrochloride Liposome Combined With BU/Cy Were Used as a Conditioning Regimen for Patients With Intermediate/Adverse Risk or Persistently Positive MRD AML
- Status
- NOT_YET_RECRUITING
- Phase
- NA
HAV Versus DAV/IAV Induction Regimen in Elderly Patients With AML
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2